(2-Chloro-4-fluoro-5-methoxyphenyl)boronic acid, 98%, 100mg

3,4-dihydroisoquinoline-2(1H)-carbothioamide, 95.0%, 1g

2-(2-Thienylidene)-3,4-dimethoxyacetophenone, 98.0%, 1g

1-chloro-9H-thioxanthen-9-one, 98%, 250mg

2,3-Bis(methylthio)quinoxaline, 90%, 250mg

2-Phenylcyclopropanamine, 90.0%, 5g

4-Fluoro-3-(trifluoromethyl)phenylboronic acid, 97.0%, 5g

5-((Benzyloxy)carbonyl)-5-azaspiro[2.4]heptane-7-carboxylic acid, 95%, 250mg

Propanoic acid, 3-[2-[[3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]amino]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 25 m, Ø-Innen 0,53 mm, Filmd. 1,00 µm, 1 Stück

2-Bromo-4-chloroanisole>98.0%(GC)25g

2-methyl-5-(trifluoromethyl)-1,3-benzothiazole, 97.0%, 5g

1-Bromo-3-methoxy-5-(trifluoromethyl)benzene, 95.0%, 100g